Goldman Sachs/Synthon
Transaction details
The proposed acquisition by Skio Bidco B.V. of sole control of Stamina TopCo B.V. (Synthon) has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:31 January 2025
- Publication date:31 January 2025
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Outcome:Cleared
Documents
M.25.008 Merger AnnouncementPDF | 152 KBM.25.008 Merger Announcement PDF | 152 KB - Opens in new window
M.25.008 DeterminationPDF | 2381 KBM.25.008 Determination PDF | 2381 KB - Opens in new window
Timetable
Parties Involved
Skio Bidco B.V.
Skio Bidco B.V. is an acquisition vehicle which is indirectly wholly-owned by Skio Topco B.V., which is wholly-owned by Skio Aggregator S.à r.l., which is indirectly owned by funds managed by Goldman Sachs & Co LLC. and the Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc.
Goldman Sachs is a global investment banking, securities and investment management firm that provides a range of banking, securities and investment services worldwide to a substantial and diversified client base. Goldman Sachs has a number of companies active in the State, which are primarily active in financial services, fund management services and aircraft leasing.
Stamina TopCo B.V.
Stamina TopCo B.V. is the ultimate holding company of Synthon. Synthon is involved in the pharmaceutical industry as a dossier developer focusing on the development, contract manufacturing, packaging and out-licensing of complex generic finished dose pharmaceuticals.
Contacts
Maximilian Tipp-McKnight maximiliantippmcknight@ccpc.ie
